Palukuru Sreedhar, Suchitra S Patil, R Nagarathna, Manjunath Netravathi, Arvinda Hanumanthapura Ramalingaiah, Spurana Honnamaranahalli Gangaraju
{"title":"Effect of Add-on Yoga in People with Multiple Sclerosis of Indian and German Cohort: A Cross-Cultural Retrospective Study.","authors":"Palukuru Sreedhar, Suchitra S Patil, R Nagarathna, Manjunath Netravathi, Arvinda Hanumanthapura Ramalingaiah, Spurana Honnamaranahalli Gangaraju","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Yoga practices have shown benefits in people with multiple sclerosis, improving their memory, fatigue, bladder symptoms, perception, stress, mood, and quality of life.</p><p><strong>Objective: </strong>This study investigates the effects of add-on yoga in people with recurrent remitting multiple sclerosis (RRMS).</p><p><strong>Materials and methods: </strong>This is a single group, pre-post retrospective study, involving 92 participants with RRMS in remission and residual symptoms, undergoing neurorehabilitation at Kuratorium Wohnen Alter (KWA) in Germany (n = 32) and SVYASA University in India (n = 60). All participants received a two-week integrated yoga module, without changes to medications. Clinical assessments were performed using a symptom checklist for Indian and the Barthel index for German participants, before and after the intervention.</p><p><strong>Results: </strong>Both groups showed significant improvements (P < .05) in their symptoms and vital parameters. The Barthel index improved by 21%, and the symptom scale by 53%. Vital parameters revealed a 5.6% and 3.3% reduction in systolic blood pressure in the German and Indian cohorts, respectively, and a 2.3% and 4.0% reduction in diastolic blood pressure in the two respective cohorts. Resting respiratory rate decreased by 13.34%, with an increase in exhalation time (humming Bhramari) by 49%, indicating reduced autonomic arousal. 26 and 50 participants in the German and Indian cohorts, respectively, were on disease-modifying agents (standard medication). Symptom analysis showed significant reductions (P < .05) in fatigue, pain, imbalance, stiffness, numbness, and impaired mobility, with gait improvement. After 7 years, the Indian cohort showed a 53% reduction in their symptom score.</p><p><strong>Conclusion: </strong>Add-on integrated yoga therapy improved symptoms and vital parameters for both Caucasian and Indian people with MS. No relapses were observed over 7 years in regular Indian yoga practitioners using disease-modifying agents.</p><p><strong>Keywords: </strong></p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"39 3","pages":"4-9"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Mind-Body Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Yoga practices have shown benefits in people with multiple sclerosis, improving their memory, fatigue, bladder symptoms, perception, stress, mood, and quality of life.
Objective: This study investigates the effects of add-on yoga in people with recurrent remitting multiple sclerosis (RRMS).
Materials and methods: This is a single group, pre-post retrospective study, involving 92 participants with RRMS in remission and residual symptoms, undergoing neurorehabilitation at Kuratorium Wohnen Alter (KWA) in Germany (n = 32) and SVYASA University in India (n = 60). All participants received a two-week integrated yoga module, without changes to medications. Clinical assessments were performed using a symptom checklist for Indian and the Barthel index for German participants, before and after the intervention.
Results: Both groups showed significant improvements (P < .05) in their symptoms and vital parameters. The Barthel index improved by 21%, and the symptom scale by 53%. Vital parameters revealed a 5.6% and 3.3% reduction in systolic blood pressure in the German and Indian cohorts, respectively, and a 2.3% and 4.0% reduction in diastolic blood pressure in the two respective cohorts. Resting respiratory rate decreased by 13.34%, with an increase in exhalation time (humming Bhramari) by 49%, indicating reduced autonomic arousal. 26 and 50 participants in the German and Indian cohorts, respectively, were on disease-modifying agents (standard medication). Symptom analysis showed significant reductions (P < .05) in fatigue, pain, imbalance, stiffness, numbness, and impaired mobility, with gait improvement. After 7 years, the Indian cohort showed a 53% reduction in their symptom score.
Conclusion: Add-on integrated yoga therapy improved symptoms and vital parameters for both Caucasian and Indian people with MS. No relapses were observed over 7 years in regular Indian yoga practitioners using disease-modifying agents.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
